Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
867.35B
Market cap867.35B
Price-Earnings ratio
40.54
Price-Earnings ratio40.54
Dividend yield
0.67%
Dividend yield0.67%
Average volume
2.80M
Average volume2.80M
High today
$932.50
High today$932.50
Low today
$905.11
Low today$905.11
Open price
$924.83
Open price$924.83
Volume
3.44M
Volume3.44M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

The current Eli Lilly(LLY) stock price is $916.99, with a market capitalization of 867.35B. The stock trades at a price-to-earnings (P/E) ratio of 40.54 and offers a dividend yield of 67.0%.

As of 2026-03-18, Eli Lilly(LLY) stock has fluctuated between $905.11 and $932.50. The current price stands at $916.99, placing the stock +1.3% above today's low and -1.7% off the high.

Eli Lilly(LLY) shares are trading with a volume of 3.44M, against a daily average of 2.8M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

LLY News

Barron's 6h
Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.

Healthcare Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look. In this article SPX GXLV SYK LLY UNH Sales growth for the he...

Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.
Benzinga 6h
Stock Of The Day: Is The Eli Lilly Selloff Over?

As you can see on the chart, in April 2025 when Eli Lilly reached the $890 level, it hit resistance. A reversal and move lower followed. When this happened, man...

Stock Of The Day: Is The Eli Lilly Selloff Over?
Simply Wall St 14h
Eli Lilly Pediatric EBGLYSS Win Offers Counterpoint To Recent Stock Weakness

Eli Lilly (NYSE:LLY) reported positive topline Phase 3 ADorable-1 results for EBGLYSS (lebrikizumab-lbkz) in pediatric patients with moderate to severe atopic d...

Eli Lilly Pediatric EBGLYSS Win Offers Counterpoint To Recent Stock Weakness

Analyst ratings

80%

of 35 ratings
Buy
80%
Hold
17.1%
Sell
2.9%

More LLY News

Nasdaq 23h
Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics

Key Points Eli Lilly is the leader in the U.S. weight loss drug market, with a 60% share. Viking aims to enter this market -- and so far, its clinical trial r...

Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics
Nasdaq 1d
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move

Key Points Hims & Hers' stock is up after ending its lawsuit with Novo Nordisk. The deal shows that industry power lies with the drugmakers. Both Novo Nordis...

Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move
Sherwood News 1d
Stocks edge higher as investors shrug off an uptick oil prices

Stocks built on yesterday’s gains in spite of the ongoing conflict in Iran. A rise in oil propelled energy stocks higher. The S&P 500, Nasdaq 100, and Russell...

Stocks edge higher as investors shrug off an uptick oil prices
The Motley Fool 1d
Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure

Artificial intelligence (AI) has been the hottest thing on Wall Street over the past three years. Many believe the technology is here to stay and will make thos...

Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure
MarketWatch 1d
Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales

Eli Lilly’s stock was downgraded over concerns about the scale and staying power of the weight-loss-drug market. In a surprising move, Eli Lilly’s stock has be...

Lilly gets rare downgrade as analysts question hype over GLP-1 pills and Zepbound’s cash sales
Nasdaq 1d
Why Eli Lilly Stock Just Dropped

Key Points HSBC analyst Rajesh Kumar downgraded Lilly stock to reduce this morning. Kumar believes GLP-1 demand, as measured in dollars, could be as little as...

Why Eli Lilly Stock Just Dropped
24/7 Wall St. 1d
Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares By David Moadel Published Mar 17, 12:27PM EDT Quick Read Eli Lill...

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.